CY1109541T1 - Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ - Google Patents
Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυInfo
- Publication number
- CY1109541T1 CY1109541T1 CY20091101271T CY091101271T CY1109541T1 CY 1109541 T1 CY1109541 T1 CY 1109541T1 CY 20091101271 T CY20091101271 T CY 20091101271T CY 091101271 T CY091101271 T CY 091101271T CY 1109541 T1 CY1109541 T1 CY 1109541T1
- Authority
- CY
- Cyprus
- Prior art keywords
- acid
- osteohthritis
- pharmaceutical formulation
- haluronic
- therapy containing
- Prior art date
Links
- ACSIXWWBWUQEHA-UHFFFAOYSA-N clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002286 clodronic acid Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002515A ITMI20052515A1 (it) | 2005-12-29 | 2005-12-29 | Formulazione farmaceutica per il trattamento della osteoartrite |
| EP06841087A EP1976538B1 (en) | 2005-12-29 | 2006-12-21 | Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109541T1 true CY1109541T1 (el) | 2014-08-13 |
Family
ID=36648609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091101271T CY1109541T1 (el) | 2005-12-29 | 2009-12-03 | Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US20090042833A1 (enExample) |
| EP (1) | EP1976538B1 (enExample) |
| JP (1) | JP2009522218A (enExample) |
| KR (2) | KR20140107651A (enExample) |
| AT (1) | ATE446763T1 (enExample) |
| AU (1) | AU2006331019B2 (enExample) |
| CA (1) | CA2646974C (enExample) |
| CY (1) | CY1109541T1 (enExample) |
| DE (1) | DE602006010111D1 (enExample) |
| DK (1) | DK1976538T3 (enExample) |
| ES (1) | ES2333615T3 (enExample) |
| IT (1) | ITMI20052515A1 (enExample) |
| NO (1) | NO340794B1 (enExample) |
| NZ (1) | NZ569420A (enExample) |
| PL (1) | PL1976538T3 (enExample) |
| PT (1) | PT1976538E (enExample) |
| RU (1) | RU2414908C2 (enExample) |
| SI (1) | SI1976538T1 (enExample) |
| WO (1) | WO2007073921A1 (enExample) |
| ZA (1) | ZA200805598B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011311859B2 (en) * | 2010-10-07 | 2015-06-04 | National Cheng Kung University | Use of hyaluronan for promoting angiogenesis |
| AU2015343845B2 (en) | 2014-11-07 | 2018-11-08 | Exostemtech Co., Ltd. | Composition for differentiation induction of adipocyte containing stem cell-derived exosome, regeneration of adipose tissue, and skin whitening or wrinkle improvement |
| KR101706642B1 (ko) | 2015-02-04 | 2017-02-17 | 주식회사 엑소스템텍 | 연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물 |
| IT201600123773A1 (it) * | 2016-12-06 | 2018-06-06 | Abiogen Pharma Spa | Composizione per il trattamento dell’osteoartrosi |
| IT202100023894A1 (it) * | 2021-09-16 | 2023-03-16 | Professional Derma Sa | Composizione per utilizzo in campo ortopedico |
| EP4450062A1 (en) * | 2023-04-20 | 2024-10-23 | Abiogen Pharma S.p.A. | Composition for the treatment of osteoarthrosis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1187828B (it) * | 1985-05-24 | 1987-12-23 | Gentili Ist Spa | Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi |
| JP2001253827A (ja) * | 2000-02-15 | 2001-09-18 | Pfizer Prod Inc | 骨粗鬆症を治療するための組成物および方法 |
| KR100492110B1 (ko) * | 2000-05-05 | 2005-06-02 | 에프. 호프만-라 로슈 아게 | 비스포스폰산 또는 그의 염을 포함하는 피하 투여용겔-유사 약학 조성물 |
| US20050287135A1 (en) * | 2002-05-17 | 2005-12-29 | Wyeth | Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| KR100648515B1 (ko) * | 2004-05-04 | 2006-11-27 | (주)아모레퍼시픽 | 비스포스포네이트-함유 고분자 미립구를 포함하는 골-관련질환 치료 또는 예방용 서방 효과를 갖는 주사제 |
-
2005
- 2005-12-29 IT IT002515A patent/ITMI20052515A1/it unknown
-
2006
- 2006-12-21 DK DK06841087T patent/DK1976538T3/da active
- 2006-12-21 WO PCT/EP2006/012367 patent/WO2007073921A1/en not_active Ceased
- 2006-12-21 PT PT06841087T patent/PT1976538E/pt unknown
- 2006-12-21 ES ES06841087T patent/ES2333615T3/es active Active
- 2006-12-21 CA CA2646974A patent/CA2646974C/en active Active
- 2006-12-21 AT AT06841087T patent/ATE446763T1/de active
- 2006-12-21 NZ NZ569420A patent/NZ569420A/en unknown
- 2006-12-21 PL PL06841087T patent/PL1976538T3/pl unknown
- 2006-12-21 US US12/159,222 patent/US20090042833A1/en not_active Abandoned
- 2006-12-21 SI SI200630473T patent/SI1976538T1/sl unknown
- 2006-12-21 AU AU2006331019A patent/AU2006331019B2/en active Active
- 2006-12-21 KR KR1020147021224A patent/KR20140107651A/ko not_active Abandoned
- 2006-12-21 RU RU2008126108/15A patent/RU2414908C2/ru active
- 2006-12-21 JP JP2008547886A patent/JP2009522218A/ja active Pending
- 2006-12-21 EP EP06841087A patent/EP1976538B1/en active Active
- 2006-12-21 ZA ZA200805598A patent/ZA200805598B/xx unknown
- 2006-12-21 DE DE602006010111T patent/DE602006010111D1/de active Active
-
2008
- 2008-06-26 NO NO20082848A patent/NO340794B1/no unknown
- 2008-06-26 KR KR1020087015583A patent/KR101470608B1/ko active Active
-
2009
- 2009-12-03 CY CY20091101271T patent/CY1109541T1/el unknown
-
2014
- 2014-09-03 US US14/476,521 patent/US9943540B2/en active Active
-
2018
- 2018-02-28 US US15/907,300 patent/US20180185407A1/en not_active Abandoned
-
2019
- 2019-12-27 US US16/728,378 patent/US20200147126A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20082848L (no) | 2008-08-27 |
| AU2006331019A1 (en) | 2007-07-05 |
| ES2333615T3 (es) | 2010-02-24 |
| AU2006331019A2 (en) | 2009-01-22 |
| RU2008126108A (ru) | 2010-01-10 |
| WO2007073921A1 (en) | 2007-07-05 |
| AU2006331019B2 (en) | 2012-03-22 |
| KR20140107651A (ko) | 2014-09-04 |
| NO340794B1 (no) | 2017-06-19 |
| US20140371170A1 (en) | 2014-12-18 |
| JP2009522218A (ja) | 2009-06-11 |
| CA2646974A1 (en) | 2007-07-05 |
| ZA200805598B (en) | 2009-11-25 |
| KR101470608B1 (ko) | 2014-12-09 |
| US20180185407A1 (en) | 2018-07-05 |
| KR20080082657A (ko) | 2008-09-11 |
| US20090042833A1 (en) | 2009-02-12 |
| US9943540B2 (en) | 2018-04-17 |
| NZ569420A (en) | 2010-05-28 |
| PT1976538E (pt) | 2009-12-07 |
| EP1976538A1 (en) | 2008-10-08 |
| PL1976538T3 (pl) | 2010-03-31 |
| CA2646974C (en) | 2013-06-11 |
| HK1123986A1 (en) | 2009-07-03 |
| DK1976538T3 (da) | 2010-01-11 |
| ATE446763T1 (de) | 2009-11-15 |
| US20200147126A1 (en) | 2020-05-14 |
| SI1976538T1 (sl) | 2010-01-29 |
| DE602006010111D1 (de) | 2009-12-10 |
| RU2414908C2 (ru) | 2011-03-27 |
| EP1976538B1 (en) | 2009-10-28 |
| ITMI20052515A1 (it) | 2007-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| UY31673A1 (es) | "derivados heterocíclicos de urea y métodos de uso de los mismos-211" | |
| BRPI0511478A (pt) | composições de vidro como aditivo antimicrobiano para materiais dentários | |
| CY1112889T1 (el) | Αναλογα αζετιδινης αναστολεων νουκλεοσιδασης και φωσφορυλασης | |
| EP2143446A4 (en) | HYBRID GEL WITH CHEMICALLY NETWORKED HYALURONIC ACID DERIVATIVE AND MEDICAMENT THEREFOR | |
| UY30759A1 (es) | Compuestos quimicos | |
| CY1115825T1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους | |
| BRPI0510428A (pt) | composições tópicas de metadona e processos para utilização das mesmas | |
| BRPI0418251C1 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
| TR200806298A2 (tr) | Farmasötik formülasyon | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| WO2009109927A3 (en) | Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer | |
| PA8720801A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento de la depresion | |
| CA3123813C (en) | IMPROVED GLIBENCLAMIDE FORMULATIONS AND RELATED FREEZE-DRYING METHODS, AND FREEZE-DRY SATE PRODUCED THUS | |
| EA200900267A1 (ru) | КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ | |
| TW200800987A (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
| ATE350377T1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
| CR9469A (es) | Derivados de urea, metodos para su fabricacion y usos para los mismos | |
| CY1109541T1 (el) | Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ | |
| GT200800107A (es) | Formulaciones orales que comprenden tigeciclina | |
| GT200600520A (es) | Agentes antibacterianos | |
| WO2010019611A3 (en) | Bridged polycyclic compound based compositions for topical and oral applications | |
| CY1109507T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια | |
| BRPI0506888A (pt) | composições de suplemento lìquido compreendendo um ou mais medicamentos |